Co-Authors
This is a "connection" page, showing publications co-authored by DAVID CORRY and EVAN LI.
Connection Strength
4.339
-
Computer-Assisted Analysis of Oral Antifungal Therapy in Chronic Rhinosinusitis with Airway Mycosis: a Retrospective Cohort Analysis. Antimicrob Agents Chemother. 2021 10 18; 65(11):e0169721.
Score: 0.822
-
The immune response to airway mycosis. Curr Opin Microbiol. 2021 08; 62:45-50.
Score: 0.806
-
Airway mycosis in allergic airway disease. Adv Immunol. 2019; 142:85-140.
Score: 0.706
-
Fungi in Mucoobstructive Airway Diseases. Ann Am Thorac Soc. 2018 11; 15(Suppl 3):S198-S204.
Score: 0.675
-
Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis. Immun Inflamm Dis. 2018 06; 6(2):264-275.
Score: 0.647
-
Mechanisms of allergy and adult asthma. Curr Opin Allergy Clin Immunol. 2020 02; 20(1):36-42.
Score: 0.184
-
Advances and Evolving Concepts in Allergic Asthma. Semin Respir Crit Care Med. 2018 Feb; 39(1):64-81.
Score: 0.160
-
A Fungal Protease Model to Interrogate Allergic Lung Immunity. Methods Mol Biol. 2018; 1799:1-9.
Score: 0.159
-
Allergen-encoded signals that control allergic responses. Curr Opin Allergy Clin Immunol. 2016 Feb; 16(1):51-8.
Score: 0.139
-
Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease. J Biol Chem. 2018 06 29; 293(26):10026-10040.
Score: 0.041